San Francisco / Seattle / Portland / Atlanta / Los Angeles / Detroit / /
Company
Health Care Resources / Unicon Research Corp. / Puget / /
Country
Puerto Rico / United States / /
Currency
USD / /
Facility
National Cancer Institute / National Hospital / Sciences University / / /
IndustryTerm
cancer prevention programs / co-insurance/co-payments / health insurance type / treatment of many patients with testis cancer / treatment of the disease / /
MedicalCondition
Urologic Diseases / Incidence Testis cancer / testicular neoplasms / I disease / Seminomas / testicular cancer / early disease / metastatic disease / regional metastases / testicular germ cell tumors / choriocarcinoma / DISCUSSION Testis cancer / late stage disease / formal testis cancer / testis cancer / higher stage disease / recurrent cancers / initial cancer / tumor / teratoma / regional and distant disease / common cancer / Testis tumors / cancer / tumors / disease / III tumors / IV tumors / localized disease / chronic disease / histological disease / distant metastases / seminoma / /
Division of Urology and Renal Transplantation / National Cancer Institute / National Hospital / Mail Code L-588 / Oregon Health and Sciences University / Medicare / National Center for Health Statistics / AMERICAN UROLOGICAL ASSOCIATION / Surgery / Oregon Health and Sciences University / Portland / Department of Surgery / National Association of Children / /
Person
Mitchell H. Sokoloff / Geoffrey F. Joyce / Matthew Wise / / /
Position
Physician / Hospital outpt Physician / /
Product
carboplatin / /
ProvinceOrState
Alaska / Oregon / Hawaii / Connecticut / New Mexico / Utah / Iowa / /
Technology
radiation / Av / Transplantation / chemotherapy / /
Testis Cancer Mitchell H. Sokoloff,* Geoffrey F. Joyce, Matthew Wise and the Urologic Diseases in America Project From the Section of Urologic Oncology, Division of Urology and Renal Transplantation, Department of Surger